Carcinoembryonic antigen (CEA), carbohydrate antigen (CA19-9), and cytokeratin 19 fragment (CYFRA21-1) are currently being considered as potential markers for diagnosing and evaluating bladder cancer, although none have been definitively established (7). This evidence concerns the gene CEACAM5 and urinary bladder cancer.